Iain Wilkie

Stock Analyst at Morgans

(0.16)
# 4,221
Out of 4,339 analysts
139
Total ratings
28.6%
Success rate
-11.4%
Average return

Stocks Rated by Iain Wilkie

Microba Life Sciences Limited
May 14, 2026
Maintained: Buy
Price Target: $0.29$0.15
Current: $0.071
Upside: +111.27%
Mach7 Technologies Limited
Apr 27, 2026
Maintained: Buy
Price Target: $0.76$0.44
Current: $0.30
Upside: +46.67%
Pro Medicus Limited
Apr 19, 2026
Maintained: Buy
Price Target: $290.00$210.00
Current: $130.35
Upside: +61.10%
Echo IQ Limited
Apr 16, 2026
Maintained: Buy
Price Target: $1.30
Current: $1.30
Upside: -
SomnoMed Limited
Mar 2, 2026
Maintained: Buy
Price Target: $0.99
Current: $0.55
Upside: +80.00%
ImExHS Limited
Mar 2, 2026
Maintained: Buy
Price Target: $0.35$0.50
Current: $0.35
Upside: +42.86%
Clinuvel Pharmaceuticals Limited
Feb 27, 2026
Maintained: Buy
Price Target: $14.00$13.00
Current: $8.89
Upside: +46.23%
Neurizon Therapeutics Limited
Feb 27, 2026
Maintained: Buy
Price Target: $0.28
Current: $0.066
Upside: +324.24%
Nanosonics Limited
Feb 25, 2026
Maintained: Buy
Price Target: $5.00$4.00
Current: $3.16
Upside: +26.58%
Proteomics International Laboratories Ltd
Feb 2, 2026
Downgraded: Sell
Price Target: $0.43
Current: $0.15
Upside: +186.67%
Maintained: Buy
Price Target: $0.58$0.24
Current: $0.005
Upside: n/a
Maintained: Buy
Price Target: $0.22$0.29
Current: $0.042
Upside: n/a
Downgraded: Sell
Price Target: $1.28$0.78
Current: $0.165
Upside: n/a
Maintained: Buy
Price Target: $1.43
Current: $0.12
Upside: n/a
Maintained: Buy
Price Target: $1.31$1.24
Current: $0.285
Upside: n/a
Maintained: Buy
Price Target: $1.89$1.64
Current: $0.017
Upside: n/a